This inventor holds 1 USPTO granted patent. Top assignees: Cornell University, Memorial Sloan Kettering Cancer Center. Active years: 2026.
Company Filing History:
1 out of 2,948 
1 out of 618 
Years Active: 2026
Title: Hari Krishna Kommidi: Innovator in Cancer Diagnostics and Treatment
Introduction
Hari Krishna Kommidi is a notable inventor based in Ithaca, NY (US). He has made significant contributions to the field of cancer diagnostics and treatment through his innovative research and patented technologies. His work focuses on developing advanced compositions and methods that enhance the detection and treatment of cancer.
Latest Patents
Kommidi holds a patent for "Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy." This patent provides compositions and methods for the detection and treatment of cancer. Specifically, the technology includes multimodal fluorine-cyanine-DOTA-hapten compositions that can be complexed with a radioisotope, such as Lutetium (Lu). The methods disclosed in this patent are aimed at improving diagnostic imaging and facilitating pretargeted radioimmunotherapy.
Career Highlights
Throughout his career, Kommidi has worked with prestigious institutions, including Memorial Sloan Kettering Cancer Center and Cornell University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.
Collaborations
Some of his notable coworkers include Nai-Kong V Cheung and Steven M Larson. Their collaborative efforts have further advanced the research and development of innovative cancer therapies.
Conclusion
Hari Krishna Kommidi's contributions to cancer diagnostics and treatment through his patented technologies highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer care and research.